<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Endoscopic ultrasound-guided fine needle aspiration in the gastrointestinal tract
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Maurits J Wiersema, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John R Saltzman, MD, FACP, FACG, FASGE, AGAF
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 20, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H109379500">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic ultrasound (EUS) is a combination of endoscopy and ultrasonography. EUS can be used to visualize and sample mass lesions of the pancreas, gastrointestinal (GI) tract, posterior mediastinum, and retroperitoneum.
        </p>
        <p>
         EUS has evolved from a diagnostic imaging modality to one that can also be used for invasive diagnostic and therapeutic procedures. These advances are largely due to the ability of EUS instruments to track a needle across an imaging plane into a target lesion. An important advantage of EUS is its ability to guide a needle to sample lesions that are too small to be identified by computed tomography (CT) or magnetic resonance imaging (MRI) or that are too well encased by surrounding vascular structures to allow for a percutaneous approach.
        </p>
        <p>
         This topic will review the technique, indications, contraindications, and adverse events related to EUS-guided fine needle aspiration (EUS-FNA) in the GI tract. A discussion on indications and technique for EUS-guided fine needle (core) biopsy (EUS-FNB) is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/2649.html" rel="external">
          "Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"
         </a>
         .)
        </p>
        <p>
         EUS-guided sampling of lesions in the mediastinum is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4395.html" rel="external">
          "Endoscopic ultrasound-guided sampling of the mediastinum: Technique, indications, contraindications, and complications"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H417376647">
         <span class="h1">
          TERMINOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic ultrasound (EUS)-guided tissue acquisition can be performed with the following methods [
         <a href="#rid1">
          1
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         EUS-guided fine needle aspiration – EUS-guided fine needle aspiration (EUS-FNA) refers to EUS-guided puncture of a lesion followed by aspiration of cells or fluid for fluid analysis (eg, tumor markers, fluid chemistries, molecular markers), cytology, or histology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         EUS-guided fine needle biopsy – EUS-guided fine needle biopsy (EUS-FNB) refers to EUS-guided core biopsy of a lesion to obtain tissue for histology.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3439469137">
         <span class="h1">
          PROCEDURE
         </span>
        </p>
        <p class="headingAnchor" id="H808522377">
         <span class="h2">
          Patient preparation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The preprocedure preparation for patients is similar to that described for patients undergoing upper gastrointestinal (GI) endoscopy (see
         <a class="medical medical_review" href="/z/d/html/13928.html" rel="external">
          "Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Patient preparation'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adjusting medications – Most patients do not need to discontinue
         <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">
          aspirin
         </a>
         or nonsteroidal anti-inflammatories when undergoing endoscopic ultrasound (EUS)-guided sampling. However, for most patients on anticoagulants and/or nonaspirin antiplatelet agents who undergo EUS-guided fine needle aspiration (EUS-FNA), the procedure-related bleeding risk is high  (
         <a class="graphic graphic_table graphicRef50700" href="/z/d/graphic/50700.html" rel="external">
          table 1
         </a>
         ). The management of antiplatelet and anticoagulant therapy in those undergoing endoscopy is typically individualized, managed in conjunction with the prescribing subspecialist, and is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2632.html" rel="external">
          "Management of antiplatelet agents in patients undergoing endoscopic procedures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2609.html" rel="external">
          "Management of anticoagulants in patients undergoing endoscopic procedures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2553.html" rel="external">
          "Gastrointestinal endoscopy in patients with disorders of hemostasis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antibiotic prophylaxis – Most patients do not need prophylactic antibiotics prior to sampling solid lesions of the GI tract, while some patients with cystic lesions require preprocedure antibiotics (eg, patients with mediastinal cysts). The indications for antibiotic prophylaxis are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2545.html" rel="external">
          "Antibiotic prophylaxis for gastrointestinal endoscopic procedures", section on 'Endoscopic ultrasound'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H109379195">
         <span class="h2">
          Equipment
         </span>
        </p>
        <p class="headingAnchor" id="H3616462737">
         <span class="h3">
          Echoendoscope
         </span>
         <span class="headingEndMark">
          —
         </span>
         EUS is performed with an echoendoscope (an endoscope with an ultrasound transducer engineered into its tip). The echoendoscope is a flexible instrument that has biopsy channels and can obtain reliable images at a depth ranging from 3 to 80 mm from the transducer. Two types of echoendoscopes exist, radial and curvilinear:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The radial echoendoscope provides a 360-degree ultrasound image of the GI tract and surrounding structures. It is purely a diagnostic tool and does not allow for FNA or FNB. The radial EUS scope readily images lesions such as submucosal lesions of the esophagus, stomach, or duodenum as the layers of the esophagus, stomach, or duodenum are clearly seen. This scope provides a familiar cross-sectional view such as that seen with CT.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The curvilinear array echoendoscope provides a 180-degree view that is in the same plane as the shaft of the echoendoscope, thereby permitting real-time visualization of the fine needle as it is advanced. This instrument has an electronic ultrasound array that scans in the long axis of the endoscope, in line with the viewing and biopsy channels. As a result, a needle advanced through the biopsy channel into the tissue of interest is in the plane of the ultrasound and thus visible in the ultrasound image in real time as an aspiration or biopsy is performed  (
         <a class="graphic graphic_diagnosticimage graphicRef68097" href="/z/d/graphic/68097.html" rel="external">
          image 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Color flow and Doppler features of the curvilinear echoendoscope also permit identification of vascular, ductular (such as biliary and pancreatic ducts), and cystic structures, which is important prior to FNA to avoid intervening blood vessels in the path of the aspiration needle.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1232892509">
         <span class="h3">
          Fine aspiration needles
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several needles are available for performing EUS-FNA, and each needle uses a catheter assembly with an attached handle mechanism that secures to the biopsy channel's Luer lock adapter on the echoendoscope. Needles range in size from 19- to 25-gauge, with a depth of penetration of up to 10 cm. Most needles have a central stylet beveled to match the needle tip, thereby enhancing the sharpness of the device.
        </p>
        <p>
         Selecting a specific needle size depends on the target lesion type, lesion location, lesion size, and endoscopist preference [
         <a href="#rid2">
          2,3
         </a>
         ] . For example, the 19-gauge needle is stiffer than a smaller (eg, 25-gauge) needle, and it may be difficult to manipulate in the duodenum with a sharply curved instrument. Smaller needles may be more easily directed and inserted into target lesions than larger needles.
        </p>
        <p class="headingAnchor" id="H109379202">
         <span class="h2">
          Technique
         </span>
         <span class="headingEndMark">
          —
         </span>
         The technical procedure of EUS-FNA of the GI tract includes selecting a site, advancing the needle, aspirating the sample, and preparing the specimen:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Selecting a site for FNA – Selecting a site for FNA includes:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Identifying a target lesion that will provide the most accurate disease stage if malignancy is suspected  (
         <a class="graphic graphic_diagnosticimage graphicRef61998" href="/z/d/graphic/61998.html" rel="external">
          image 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/2502.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of esophageal cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Examining the target location with Doppler imaging to avoid blood vessels and other structures that may be located between the tip of the echoendoscope containing the needle and the target lesion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Advancing the needle catheter apparatus – After a target lesion without intervening blood vessels has been identified, the needle catheter apparatus (containing a needle that is retracted into the sheath) is advanced through the working channel of the curvilinear echoendoscope with the endoscope's elevator in the down position. The needle apparatus is advanced into the endoscope until the device meets the insertion site of the biopsy channel's Luer lock adapter, and then the apparatus is secured in place.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Some degree of balloon insufflation at the tip of the echoendoscope may be necessary to allow acoustic coupling. To prevent puncturing the balloon with the needle tip, luminal pressure can be applied with the up/down dial of the echoendoscope.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obtaining the specimen – Under direct ultrasound guidance, the needle is directed through the wall of the GI organ nearest to the target lesion (eg, stomach, duodenum) and then into the lesion. A swift jabbing motion is occasionally necessary to traverse the muscularis propria and enter the lesion. When the needle has entered the lesion of interest, the stylet is withdrawn, and a 10 or 20 mL syringe is attached to the needle apparatus. Aspiration is then performed by simultaneously moving the needle in a to-and-fro motion inside the target lesion and fanning the target lesion while applying negative pressure using the syringe [
         <a href="#rid4">
          4
         </a>
         ]. After the sample is obtained (but prior to removing the needle), the negative pressure should be released (this should be done by releasing the syringe plunger while not forcing it back to its neutral position). Reduced negative pressure (ie, by 1 to 2 mL) or the use of smaller-gauge needles (ie, 25-gauge) may result in less bloody aspirates, particularly with vascular tumors or lymph nodes. The needle apparatus is then removed from the echoendoscope.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Some advanced endoscopists prefer to pull back the stylet only in order to create negative pressure, rather than using a syringe. If a specimen is not obtained using this method, the stylet is withdrawn, and a syringe is used to create suction. Conversely, if the aspirated sample is bloody during initial sampling using a syringe, further sampling may be performed without the negative pressure from the syringe.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preparing and assessing the specimen – To prepare the specimen after removing the needle apparatus, air is forced through the needle using the same syringe, which expels the aspirated sample. This may be done into a cytologic preservative or applied directly onto a glass slide.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For rapid on-site evaluation (ROSE), two direct smears are usually made from a single pass; one slide is fixed with 95 percent alcohol for cytologic analysis in the laboratory, while the other slide is air dried and stained [
         <a href="#rid5">
          5
         </a>
         ]. After the material has been smeared onto the glass slides, a
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         wash is performed through the needle, and the material is collected to be made into a cell block. The stylet is then wiped off to remove any remaining blood and the needle purged of any remaining fluid using air. The entire needle device can then be reassembled for additional passes into the lesion.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Number of FNA passes – Multiple passes can be performed to enhance the diagnostic yield as well as for special staining, or for microbiology purposes (eg, for patients with suspected lymphoma who require flow cytometry testing of the specimen). The same procedure can be used to aspirate tissue for microbiologic analysis, except the aspirate is placed in a small amount of sterile
         <a class="drug drug_general" data-topicid="9929" href="/z/d/drug information/9929.html" rel="external">
          saline
         </a>
         .
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a cytotechnologist or cytopathologist is present during the procedure to examine the slides, they can indicate when a sufficient cellular sample has been obtained. If a cytotechnologist or cytopathologist is not present, three passes are taken through lymph nodes and five to six passes are taken through pancreatic masses to ensure adequate cellularity in &gt;90 percent of cases [
         <a href="#rid6">
          6,7
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The optimal number of aspirates that are needed for achieving diagnostic accuracy is uncertain [
         <a href="#rid7">
          7,8
         </a>
         ]. As an example, in a study including 95 patients with a variety of lesions estimated that at least seven passes were required for pancreatic and other non-lymph node lesions, while five passes appeared to be sufficient for lymph nodes [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3591178867">
         <span class="h2">
          Postprocedure care
         </span>
         <span class="headingEndMark">
          —
         </span>
         After the procedure, patients are recovered from sedation or anesthesia. A fever after the procedure is not typical and warrants further investigation, although bacteremia is rare. (See
         <a class="local">
          'Adverse events'
         </a>
         below.)
        </p>
        <p>
         The equipment is cleaned per procedural protocol. (See
         <a class="medical medical_review" href="/z/d/html/2672.html" rel="external">
          "Preventing infection transmitted by gastrointestinal endoscopy", section on 'Overview of endoscope reprocessing'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3252836518">
         <span class="h1">
          INDICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H4031038009">
         <span class="h2">
          Diagnostic role of FNA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is used to sample lesions within or adjacent to the gastrointestinal (GI) tract; peri-intestinal structures such as lymph nodes; and masses in the pancreas, liver, adrenal gland, and bile duct. It has also been used to sample mucosal and submucosal lesions in which prior endoscopic biopsies have been nondiagnostic. Less commonly, it is used to aspirate peritoneal and pleural fluid.
        </p>
        <p>
         Limitations of EUS-FNA include availability of equipment and endoscopic expertise, and the rare occurrence of false-negative or false-positive results that may lead to unnecessary surgery and are mostly related to interpretation of cytologic material [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4125709187">
         <span class="h2">
          Lesion type
         </span>
        </p>
        <p class="headingAnchor" id="H109379223">
         <span class="h3">
          Pancreatic lesions
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Solid pancreatic lesions – The role of EUS in the diagnostic evaluation and staging of pancreatic masses is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2501.html" rel="external">
          "Clinical manifestations, diagnosis, and staging of exocrine pancreatic cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5638.html" rel="external">
          "Endoscopic ultrasound in the staging of exocrine pancreatic cancer"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Pancreatic lesions that are suspicious for metastases can also be visualized and sampled with EUS [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pancreatic neuroendocrine tumors – EUS can identify pancreatic neuroendocrine tumors (NETs), and EUS-FNA can provide nonoperative diagnosis with reported sensitivity ranging from 68 to 87 percent and specificity ranging from 86 to 100 percent [
         <a href="#rid11">
          11-13
         </a>
         ]. The diagnosis and staging of pancreatic NETs is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2612.html" rel="external">
          "Classification, epidemiology, clinical presentation, localization, and staging of pancreatic neuroendocrine neoplasms"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cystic pancreatic lesions – EUS-FNA of pancreatic and peripancreatic cysts permits fluid analysis, while also demonstrating imaging characteristics [
         <a href="#rid14">
          14,15
         </a>
         ]. The cyst fluid obtained via EUS-FNA can be analyzed for cytology, tumor markers, and molecular markers  (
         <a class="graphic graphic_table graphicRef57759" href="/z/d/graphic/57759.html" rel="external">
          table 2
         </a>
         ), and this is discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'EUS-FNA findings associated with specific cysts'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         EUS features suggestive of specific cyst types (eg, serous cystic tumors, mucinous cystic neoplasms, intraductal papillary mucinous neoplasms) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5637.html" rel="external">
          "Classification of pancreatic cysts"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5642.html" rel="external">
          "Pancreatic cystic neoplasms: Clinical manifestations, diagnosis, and management", section on 'EUS-FNA findings associated with specific cysts'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1622812682">
         <span class="h3">
          Peri-intestinal lymph nodes
         </span>
         <span class="headingEndMark">
          —
         </span>
         EUS-FNA can provide sampling of peri-intestinal lymph nodes for patients with lymphadenopathy [
         <a href="#rid16">
          16-19
         </a>
         ]. In a study including 183 lymph nodes that were sampled by EUS-FNA, the sensitivity and specificity of FNA were 98 and 100 percent, respectively [
         <a href="#rid19">
          19
         </a>
         ]. In addition, EUS-FNA was more accurate compared with EUS evaluation alone (99 versus 75 percent). The role of EUS-FNA in sampling lymph nodes and staging for patients with esophageal cancer is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/2663.html" rel="external">
          "Endoscopic ultrasound for evaluating patients with esophageal cancer", section on 'Endoscopic ultrasound-guided fine-needle aspiration biopsy'
         </a>
         .)
        </p>
        <p>
         EUS-FNA has been useful for the diagnosis of other disorders associated with lymphadenopathy such as Hodgkin and non-Hodgkin lymphoma, particularly if flow cytometry is used [
         <a href="#rid20">
          20,21
         </a>
         ]. Cytology can be used to diagnose large cell non-Hodgkin lymphoma, but is more limited in low-grade lesions [
         <a href="#rid22">
          22
         </a>
         ]. For some patients with suspected lymphoma, samples may be obtained by using EUS-FNA initially and then by using EUS-guided fine needle biopsy (EUS-FNB) if onsite cytopathology suggests the need for core tissue. (See
         <a class="medical medical_review" href="/z/d/html/2649.html" rel="external">
          "Endoscopic ultrasound-guided fine needle biopsy in the gastrointestinal tract"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H109379258">
         <span class="h3">
          Upper GI tract lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Esophageal or gastric wall thickening can be evaluated with EUS-FNA. As an example, in a study of EUS-FNA evaluation of 103 lesions arising from the GI wall (excluding stromal tumors), sensitivity varied with the type of lesion (eg, 89 percent for non-Hodgkin gastric lymphoma compared with 40 percent for gastric adenocarcinoma) [
         <a href="#rid16">
          16
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/34.html" rel="external">
          "Approach to the patient with large gastric folds"
         </a>
         .)
        </p>
        <p>
         EUS-guided detection and tissue acquisition of subepithelial lesions of the upper GI tract (eg, GI stromal tumors [GISTs]) is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2666.html" rel="external">
          "Endoscopic ultrasound for the characterization of subepithelial lesions of the upper gastrointestinal tract"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7745.html" rel="external">
          "Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2175293625">
         <span class="h3">
          Lower GI tract lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lower GI tract lesions such as suspected GIST or perirectal mass lesions can be evaluated with EUS-FNA. However, FNA is infrequently required for evaluating lesions in the lower GI tract [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2674.html" rel="external">
          "Endoscopic ultrasound for evaluating patients with rectal cancer"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7745.html" rel="external">
          "Clinical presentation, diagnosis, and prognosis of gastrointestinal stromal tumors", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H109379265">
         <span class="h3">
          Other lesions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other lesions that can be sampled using EUS-FNA include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bile duct strictures and gallbladder masses – EUS-FNA has been used in the evaluation of bile duct strictures and gallbladder masses, and it is often performed in addition to endoscopic retrograde cholangiopancreatography (ERCP) and brush cytology [
         <a href="#rid24">
          24,25
         </a>
         ]. However, for patients with suspected cholangiocarcinoma, EUS-FNA is reserved for patients who are not candidates for liver transplantation. EUS-FNA can rarely result in seeding of the biopsy tract with malignant cells, which may preclude an otherwise eligible transplantation candidate from undergoing liver transplantation. The diagnosis and staging of cholangiocarcinoma is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2500.html" rel="external">
          "Clinical manifestations and diagnosis of cholangiocarcinoma"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The diagnostic accuracy of EUS-FNA for biliary and gallbladder lesions has been evaluated in multiple studies [
         <a href="#rid25">
          25-27
         </a>
         ]. In a meta-analysis of 20 studies including 957 patients, the sensitivity of EUS-FNA for detecting malignant biliary strictures was 80 percent, and specificity was 97 percent [
         <a href="#rid27">
          27
         </a>
         ]. In another meta-analysis of nine studies including 284 patients with bile duct or gallbladder lesions, EUS-FNA was 84 percent sensitive and 100 percent specific for diagnosing bile duct and gallbladder cancers [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Uncommon uses – Small case series and case reports have suggested that EUS-guided FNA may be useful for sampling solid liver lesions [
         <a href="#rid16">
          16,28,29
         </a>
         ], adrenal lesions [
         <a href="#rid30">
          30
         </a>
         ], or peritoneal fluid [
         <a href="#rid31">
          31,32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2884125847">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are few contraindications for endoscopic ultrasound-guided fine needle aspiration (EUS-FNA); however, the most common contraindications are related to routine upper endoscopy and include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who cannot tolerate moderate sedation, monitored anesthesia care (MAC), or general anesthesia. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who are hemodynamically unstable.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with gastrointestinal (GI) obstruction (eg, duodenal stricture due to a lesion in the head of the pancreas) may undergo EUS, but the imaging is limited to an area proximal to the level of obstruction.
        </p>
        <p>
        </p>
        <p>
         For patients with abnormal coagulation studies (platelet count ≤50,000/microL; international normalized ratio [INR] &gt;1.5), EUS-FNA is relatively contraindicated. Management of anticoagulants and antiplatelet agents for patients undergoing endoscopic procedures is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2609.html" rel="external">
          "Management of anticoagulants in patients undergoing endoscopic procedures"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2632.html" rel="external">
          "Management of antiplatelet agents in patients undergoing endoscopic procedures"
         </a>
         .)
         <strong>
         </strong>
        </p>
        <p class="headingAnchor" id="H109379272">
         <span class="h1">
          ADVERSE EVENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Endoscopic ultrasound (EUS) and EUS-guided sampling are generally safe procedures. Some complications are due to the effect of procedural sedation (eg, hypotension), while others are due to the endoscopy itself or the sampling procedure. In a pooled series of nearly 2500 patients who underwent EUS-guided fine needle aspiration (EUS-FNA), the overall rate of adverse events ranged from 0 to 3 percent, and complications mostly included infection, bleeding, and pancreatitis [
         <a href="#rid33">
          33,34
         </a>
         ]. Mortality was very rare, with one death reported (0.04 percent).
        </p>
        <p>
         However, a higher rate of adverse events was reported in a subsequent study that was limited to 502 patients who underwent lower gastrointestinal (GI) EUS-FNA [
         <a href="#rid23">
          23
         </a>
         ]. Overall, adverse events developed in 103 patients (21 percent), and serious adverse events were seen in 28 patients (6 percent). The most commonly reported serious adverse events were pain (5 percent) and bleeding (0.6 percent), while risk factors for adverse events included preprocedure pain, malignant lesion, and lesion site other than lymph node or intestinal wall. In addition, EUS-FNA is infrequently required for evaluating lesions in the lower GI tract. (See
         <a class="local">
          'Lower GI tract lesions'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1483042675">
         <span class="h2">
          Endoscopy-related
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complications associated with EUS may be due to the upper GI endoscopy itself (without FNA) and/or the associated sedation and anesthesia (eg, hypotension) [
         <a href="#rid35">
          35
         </a>
         ]. These complications are discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2599.html" rel="external">
          "Adverse events related to procedural sedation for gastrointestinal endoscopy in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13928.html" rel="external">
          "Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Complications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1092199238">
         <span class="h2">
          FNA-related
         </span>
         <span class="headingEndMark">
          —
         </span>
         Reported complications of FNA are generally rare and include [
         <a href="#rid36">
          36
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infection such as bacteremia (rare) [
         <a href="#rid37">
          37-39
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bleeding (usually minor; hemorrhage requiring transfusion is rare)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Needle tracking with malignant or infectious cells (rare) [
         <a href="#rid40">
          40-47
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pancreatitis after sampling of solid or cystic pancreatic lesion (rare) [
         <a href="#rid33">
          33,48
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H109379509">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          General principles
         </strong>
         – Endoscopic ultrasound (EUS) is a combination of endoscopy and ultrasonography. EUS can be used to visualize and sample lesions of the pancreas, gastrointestinal (GI) tract, posterior mediastinum, and retroperitoneum. EUS is an imaging modality that can be used diagnostically and for invasive diagnostic and therapeutic procedures. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         EUS-guided tissue acquisition can be performed with the following methods (see
         <a class="local">
          'Terminology'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         EUS-guided fine needle aspiration – EUS-guided fine needle aspiration (EUS-FNA) refers to EUS-guided puncture of a lesion followed by aspirating cells or fluid for fluid analysis, cytology, or histology.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         EUS-guided fine needle biopsy – EUS-guided fine needle biopsy (EUS-FNB) refers to EUS-guided core biopsy of a lesion to obtain tissue for histology.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Procedure
         </strong>
         – EUS is performed with an echoendoscope (an endoscope with an ultrasound transducer in its tip). While radial EUS can provide diagnostic imaging, curvilinear EUS provides real-time ultrasonographic guidance for fine needle aspiration (EUS-FNA). The technical procedure of EUS-FNA of the GI tract includes selecting a site, advancing the needle, aspirating the sample, and processing the specimen. (See
         <a class="local">
          'Technique'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pre- and postprocedure care
         </strong>
         – Pre- and postprocedure care is similar to that for patients who undergo upper GI endoscopy. (See
         <a class="local">
          'Procedure'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/13928.html" rel="external">
          "Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Clinical applications
         </strong>
         – EUS-FNA is used to sample lesions within or proximal to the GI tract; peri-intestinal structures such as lymph nodes; and masses in the pancreas, liver, adrenal gland, and bile duct. (See
         <a class="local">
          'Indications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Contraindications
         </strong>
         – There are few contraindications for EUS-guided sampling; however, the most common contraindications are related to upper endoscopy itself, including hemodynamic instability, inability to tolerate anesthesia/sedation, and GI obstruction. (See
         <a class="local">
          'Contraindications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Adverse events
         </strong>
         – EUS and EUS-guided sampling are generally safe procedures, and complications are infrequently reported. Some complications are due to the effect of procedural sedation (eg, hypotension), while others are due to the endoscopy itself or the sampling procedure (infection, bleeding, pancreatitis). (See
         <a class="local">
          'Adverse events'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H10270881">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Ian D Norton, MBBS, PhD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Cazacu IM, Luzuriaga Chavez AA, Saftoiu A, et al. A quarter century of EUS-FNA: Progress, milestones, and future directions. Endosc Ultrasound 2018; 7:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tian G, Bao H, Li J, Jiang T. Systematic Review and Meta-Analysis of Diagnostic Accuracy of Endoscopic Ultrasound (EUS)-Guided Fine-Needle Aspiration (FNA) Using 22-gauge and 25-gauge Needles for Pancreatic Masses. Med Sci Monit 2018; 24:8333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Madhoun MF, Wani SB, Rastogi A, et al. The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis. Endoscopy 2013; 45:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen AM, Thosani NC, Friedland S, et al. 99 Prospective randomized blind controlled trial of capillary EUS-FNA vs. suction EUS-FNA for the diagnosis of solid tumors. Gastrointest Endosc 2014; 79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace MB, Kennedy T, Durkalski V, et al. Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy. Gastrointest Endosc 2001; 54:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Erickson RA, Sayage-Rabie L, Beissner RS. Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies. Gastrointest Endosc 2000; 51:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong CCN, Lakhtakia S, Nguyen N, et al. Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial. Endoscopy 2020; 52:856.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           LeBlanc JK, Ciaccia D, Al-Assi MT, et al. Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis. Gastrointest Endosc 2004; 59:475.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schwartz DA, Unni KK, Levy MJ, et al. The rate of false-positive results with EUS-guided fine-needle aspiration. Gastrointest Endosc 2002; 56:868.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeWitt J, Jowell P, Leblanc J, et al. EUS-guided FNA of pancreatic metastases: a multicenter experience. Gastrointest Endosc 2005; 61:689.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ardengh JC, de Paulo GA, Ferrari AP. EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery. Gastrointest Endosc 2004; 60:378.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Turner BG, Cizginer S, Agarwal D, et al. Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy. Gastrointest Endosc 2010; 71:91.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pais SA, Al-Haddad M, Mohamadnejad M, et al. EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience. Gastrointest Endosc 2010; 71:1185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sedlack R, Affi A, Vazquez-Sequeiros E, et al. Utility of EUS in the evaluation of cystic pancreatic lesions. Gastrointest Endosc 2002; 56:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brandwein SL, Farrell JJ, Centeno BA, Brugge WR. Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS. Gastrointest Endosc 2001; 53:722.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiersema MJ, Vilmann P, Giovannini M, et al. Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment. Gastroenterology 1997; 112:1087.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhutani MS, Hawes RH, Hoffman BJ. A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion. Gastrointest Endosc 1997; 45:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis JD, Faigel DO, Dowdy Y, et al. Hodgkin's disease diagnosed by endoscopic ultrasound-guided fine needle aspiration of a periduodenal lymph node. Am J Gastroenterol 1998; 93:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen VK, Eloubeidi MA. Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy. Am J Gastroenterol 2004; 99:628.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ribeiro A, Vazquez-Sequeiros E, Wiersema LM, et al. EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma. Gastrointest Endosc 2001; 53:485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wiersema MJ, Gatzimos K, Nisi R, Wiersema LM. Staging of non-Hodgkin's gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry. Gastrointest Endosc 1996; 44:734.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pilotti S, Di Palma S, Alasio L, et al. Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration. Acta Cytol 1993; 37:853.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy MJ, Abu Dayyeh BK, Fujii LL, et al. Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA. Am J Gastroenterol 2014; 109:676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeWitt J, Misra VL, Leblanc JK, et al. EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest Endosc 2006; 64:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Moura DTH, Ryou M, de Moura EGH, et al. Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography-Based Tissue Sampling in Suspected Malignant Biliary Strictures: A Meta-Analysis of Same-Session Procedures. Clin Endosc 2020; 53:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu LM, Jiang XX, Gu HY, et al. Endoscopic ultrasound-guided fine-needle aspiration biopsy in the evaluation of bile duct strictures and gallbladder masses: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2011; 23:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadeghi A, Mohamadnejad M, Islami F, et al. Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis. Gastrointest Endosc 2016; 83:290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience. Am J Gastroenterol 2003; 98:1976.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh P, Erickson RA, Mukhopadhyay P, et al. EUS for detection of the hepatocellular carcinoma: results of a prospective study. Gastrointest Endosc 2007; 66:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang KJ, Erickson RA, Nguyen P. Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration of the left adrenal gland. Gastrointest Endosc 1996; 44:568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaushik N, Khalid A, Brody D, McGrath K. EUS-guided paracentesis for the diagnosis of malignant ascites. Gastrointest Endosc 2006; 64:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeWitt J, LeBlanc J, McHenry L, et al. Endoscopic ultrasound-guided fine-needle aspiration of ascites. Clin Gastroenterol Hepatol 2007; 5:609.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eloubeidi MA, Gress FG, Savides TJ, et al. Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States. Gastrointest Endosc 2004; 60:385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polkowski M, Larghi A, Weynand B, et al. Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline. Endoscopy 2012; 44:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wallace MB, Hawes RH, Sahai AV, et al. Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management. Gastrointest Endosc 2000; 51:309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alvarez-Sánchez MV, Jenssen C, Faiss S, Napoléon B. Interventional endoscopic ultrasonography: an overview of safety and complications. Surg Endosc 2014; 28:712.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barawi M, Gottlieb K, Cunha B, et al. A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levy MJ, Norton ID, Wiersema MJ, et al. Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA. Gastrointest Endosc 2003; 57:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Janssen J, König K, Knop-Hammad V, et al. Frequency of bacteremia after linear EUS of the upper GI tract with and without FNA. Gastrointest Endosc 2004; 59:339.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Katanuma A, Maguchi H, Hashigo S, et al. Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas. Endoscopy 2012; 44 Suppl 2 UCTN:E160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah JN, Fraker D, Guerry D, et al. Melanoma seeding of an EUS-guided fine needle track. Gastrointest Endosc 2004; 59:923.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paquin SC, Gariépy G, Lepanto L, et al. A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma. Gastrointest Endosc 2005; 61:610.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doi S, Yasuda I, Iwashita T, et al. Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy. Gastrointest Endosc 2008; 67:988.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirooka Y, Goto H, Itoh A, et al. Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination. J Gastroenterol Hepatol 2003; 18:1323.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong A, Venugopal K, Segarajasingam D, Lisewski D. Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia. Gastrointest Endosc 2011; 74:933.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoon WJ, Daglilar ES, Fernández-del Castillo C, et al. Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study. Endoscopy 2014; 46:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ngamruengphong S, Xu C, Woodward TA, et al. Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needle aspiration. Endoscopy 2013; 45:619.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee LS, Saltzman JR, Bounds BC, et al. EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors. Clin Gastroenterol Hepatol 2005; 3:231.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2656 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29941723" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A quarter century of EUS-FNA: Progress, milestones, and future directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30452433" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Systematic Review and Meta-Analysis of Diagnostic Accuracy of Endoscopic Ultrasound (EUS)-Guided Fine-Needle Aspiration (FNA) Using 22-gauge and 25-gauge Needles for Pancreatic Masses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23307148" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : The diagnostic accuracy of 22-gauge and 25-gauge needles in endoscopic ultrasound-guided fine needle aspiration of solid pancreatic lesions: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : 99 Prospective randomized blind controlled trial of capillary EUS-FNA vs. suction EUS-FNA for the diagnosis of solid tumors
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11577304" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Randomized controlled trial of EUS-guided fine needle aspiration techniques for the detection of malignant lymphadenopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10650262" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Factors predicting the number of EUS-guided fine-needle passes for diagnosis of pancreatic malignancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32498098" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Endoscopic ultrasound-guided tissue acquisition with or without macroscopic on-site evaluation: randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15044881" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Optimal number of EUS-guided fine needle passes needed to obtain a correct diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12447300" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : The rate of false-positive results with EUS-guided fine-needle aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15855973" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : EUS-guided FNA of pancreatic metastases: a multicenter experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15332027" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : EUS-guided FNA in the diagnosis of pancreatic neuroendocrine tumors before surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19846087" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Diagnosis of pancreatic neoplasia with EUS and FNA: a report of accuracy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20304401" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : EUS for pancreatic neuroendocrine tumors: a single-center, 11-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12297771" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Utility of EUS in the evaluation of cystic pancreatic lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11375578" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Detection and tumor staging of malignancy in cystic, intraductal, and solid tumors of the pancreas by EUS.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9097990" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Endosonography-guided fine-needle aspiration biopsy: diagnostic accuracy and complication assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9199903" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : A comparison of the accuracy of echo features during endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration for diagnosis of malignant lymph node invasion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9625141" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Hodgkin's disease diagnosed by endoscopic ultrasound-guided fine needle aspiration of a periduodenal lymph node.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15089893" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Endoscopic ultrasound-guided fine needle aspiration is superior to lymph node echofeatures: a prospective evaluation of mediastinal and peri-intestinal lymphadenopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11275890" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : EUS-guided fine-needle aspiration combined with flow cytometry and immunocytochemistry in the diagnosis of lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8979069" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Staging of non-Hodgkin's gastric lymphoma with endosonography-guided fine-needle aspiration biopsy and flow cytometry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8249502" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24469614" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prospective evaluation of adverse events following lower gastrointestinal tract EUS FNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16923477" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31684700" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Endoscopic Ultrasound-Guided Fine Needle Aspiration and Endoscopic Retrograde Cholangiopancreatography-Based Tissue Sampling in Suspected Malignant Biliary Strictures: A Meta-Analysis of Same-Session Procedures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21183858" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Endoscopic ultrasound-guided fine-needle aspiration biopsy in the evaluation of bile duct strictures and gallbladder masses: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26422979" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Diagnostic yield of EUS-guided FNA for malignant biliary stricture: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14499774" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Endoscopic ultrasound-guided fine needle aspiration cytology of solid liver lesions: a large single-center experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17543307" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : EUS for detection of the hepatocellular carcinoma: results of a prospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8934163" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Endoscopic ultrasound (EUS) and EUS-guided fine-needle aspiration of the left adrenal gland.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17140897" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : EUS-guided paracentesis for the diagnosis of malignant ascites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17336593" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Endoscopic ultrasound-guided fine-needle aspiration of ascites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15332028" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Acute pancreatitis after EUS-guided FNA of solid pancreatic masses: a pooled analysis from EUS centers in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22180307" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10699776" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Dilation of malignant esophageal stenosis to allow EUS guided fine-needle aspiration: safety and effect on patient management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24196551" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Interventional endoscopic ultrasonography: an overview of safety and complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11174290" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : A prospective evaluation of the incidence of bacteremia associated with EUS-guided fine-needle aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12709695" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Prospective risk assessment of bacteremia and other infectious complications in patients undergoing EUS-guided FNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14997128" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Frequency of bacteremia after linear EUS of the upper GI tract with and without FNA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22622721" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Tumor seeding after endoscopic ultrasound-guided fine-needle aspiration of cancer in the body of the pancreas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15173817" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Melanoma seeding of an EUS-guided fine needle track.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15812422" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : A first report of tumor seeding because of EUS-guided FNA of a pancreatic adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18279861" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14535994" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Case of intraductal papillary mucinous tumor in which endosonography-guided fine-needle aspiration biopsy caused dissemination.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21951481" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Tumor seeding after EUS-guided FNA of pancreatic tail neoplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24619804" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Peritoneal seeding in intraductal papillary mucinous neoplasm of the pancreas patients who underwent endoscopic ultrasound-guided fine-needle aspiration: the PIPE Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23881804" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Risk of gastric or peritoneal recurrence, and long-term outcomes, following pancreatic cancer resection with preoperative endosonographically guided fine needle aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15765442" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : EUS-guided fine needle aspiration of pancreatic cysts: a retrospective analysis of complications and their predictors.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
